000 01425 a2200409 4500
005 20250516034937.0
264 0 _c20120716
008 201207s 0 0 eng d
022 _a1476-5365
024 7 _a10.1038/bmt.2011.97
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGuilcher, G M T
245 0 0 _aSingle-agent high-dose melphalan followed by auto-SCT for relapsed and refractory Hodgkin lymphoma in children and adolescents.
_h[electronic resource]
260 _bBone marrow transplantation
_cMar 2012
300 _a395-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aCanada
650 0 4 _aChild
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aFemale
650 0 4 _aHodgkin Disease
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aLymphoma
_xtherapy
650 0 4 _aMale
650 0 4 _aMelphalan
_xadministration & dosage
650 0 4 _aMyeloablative Agonists
_xadministration & dosage
650 0 4 _aRecurrence
650 0 4 _aRetrospective Studies
650 0 4 _aStem Cell Transplantation
_xmethods
650 0 4 _aTransplantation Conditioning
_xmethods
700 1 _aRizzuti, F A
700 1 _aLewis, V A
700 1 _aStewart, D A
773 0 _tBone marrow transplantation
_gvol. 47
_gno. 3
_gp. 395-8
856 4 0 _uhttps://doi.org/10.1038/bmt.2011.97
_zAvailable from publisher's website
999 _c20815744
_d20815744